Reprinted with permission from AlterNet.
It should come as no shock that Trump has nominated Alex Michael Azar II, a former Pharma executive and lobbyist, to head the Department of Health and Human Services (HHS). After all, Trump named Scott Gottlieb, a Pharma consultant and stock speculator FDA Commissioner and EPA opponent Scott Pruitt to be head of the EPA. Azar would replace Tom Price, who resigned amid a scandal over his use of taxpayer money for his personal and official travel.
While serving as president of Lilly USA, Azar presided over a tripling of the price of its insulin.…